- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:diseases:gerd [09.05.2012] – [Patients experiences] paulalbert | home:diseases:gerd [09.05.2012] – [Stomach and esophageal disorders] paulalbert | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| ====== Stomach and esophageal disorders ====== | ====== Stomach and esophageal disorders ====== | ||
| + | Proton-pump inhibitors such as omeprazole (Prilosec) can be used only if adjusting Marshall Protocol (MP) meds and use of [[home: | ||
| - | + | Types of stomach and esophageal disorders are as follows: | |
| - | + | * **Barrett' | |
| + | * **dyspepsia** – also known as upset stomach or indigestion, | ||
| + | * gastrointestinal esophageal reflux disease (GERD) | ||
| ===== GERD (gastrointestinal esophageal reflux disease) ===== | ===== GERD (gastrointestinal esophageal reflux disease) ===== | ||
| Line 17: | Line 19: | ||
| ==== Management ==== | ==== Management ==== | ||
| + | |||
| + | |||
| + | === Low-carbohydrate diet === | ||
| + | |||
| + | < | ||
| + | |||
| + | {{section>: | ||
| + | |||
| Line 23: | Line 33: | ||
| An antacid is any substance, generally a base or basic salt, which counteracts stomach acidity. Antacids are not contraindicated for Marshall Protocol (MP) patients. As with other over-the-counter medications and supplements, | An antacid is any substance, generally a base or basic salt, which counteracts stomach acidity. Antacids are not contraindicated for Marshall Protocol (MP) patients. As with other over-the-counter medications and supplements, | ||
| - | MP patients should not take antacids | + | Note, however, that according to a recent literature review, |
| + | MP patients should not take antacids at least one hour before or two hours after taking other medications. | ||
| === Proton-pump inhibitors === | === Proton-pump inhibitors === | ||
| Line 93: | Line 103: | ||
| - | {{tag> | + | {{tag> |
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| ===== References ===== | ===== References ===== | ||
home/diseases/gerd.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.